TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO)

Bibliographic Details
Title: TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO)
Authors: Federico Martinón-Torres, Adolfo García-Sastre, Andrew J. Pollard, Carlos Martín, Albert Osterhaus, Shamez N Ladhani, Octavio Ramilo, Jose Gómez Rial, Antonio Salas, F Xavier Bosch, María Martinón-Torres, Michael J. Mina, James Cherry
Source: Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4299-4327 (2021)
Publisher Information: Taylor & Francis Group, 2021.
Publication Year: 2021
Collection: LCC:Immunologic diseases. Allergy
LCC:Therapeutics. Pharmacology
Subject Terms: infectious disease, vaccine-preventable disease, covid-19 pandemic, control of transmission, vaccine-immunity response, severe acute respiratory syndrome coronavirus-2 (sars-cov-2), Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950
More Details: TIPiCO is an annual expert meeting and workshop on infectious diseases and vaccination. The edition of 2020 changed its name and format to aTIPiCO, the first series and podcasts on infectious diseases and vaccines. A total of 13 prestigious experts from different countries participated in this edition launched on the 26 November 2020. The state of the art of coronavirus disease-2019 (COVID-19) and the responsible pathogen, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the options to tackle the pandemic situation were discussed in light of the knowledge in November 2020. Despite COVID-19, the status of other infectious diseases, including influenza infections, respiratory syncytial virus disease, human papillomavirus infection, measles, pertussis, tuberculosis, meningococcal disease, and pneumococcal disease, were also addressed. The essential lessons that can be learned from these diseases and their vaccines to use in the COVID-19 pandemic were also commented with the experts.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2164-5515
2164-554X
21645515
Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X
DOI: 10.1080/21645515.2021.1953351
Access URL: https://doaj.org/article/74e6baa52ef14d27bb0d3f6686a4d1d4
Accession Number: edsdoj.74e6baa52ef14d27bb0d3f6686a4d1d4
Database: Directory of Open Access Journals
More Details
ISSN:21645515
2164554X
DOI:10.1080/21645515.2021.1953351
Published in:Human Vaccines & Immunotherapeutics
Language:English